Citation tools
"Cardioprotective and Survival Benefits of Long-Term Combined Therapy with β2 Adrenoreceptor (AR) Agonist and β1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction." Journal of Pharmacology and Experimental Therapeutics
325.2
(2008):
491-499.
Web. 19 April. 2024.